Imagion Biosystems Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was AUD 1.65 million compared to AUD 0.569959 million a year ago. Revenue was AUD 5.18 million compared to AUD 3.07 million a year ago.

Net loss was AUD 13.07 million compared to AUD 9.81 million a year ago. Basic loss per share from continuing operations was AUD 0.00429 compared to AUD 0.00348 a year ago. Diluted loss per share from continuing operations was AUD 0.00429 compared to AUD 0.00348 a year ago.